Human Microbiome Applications in IVD and Other Healthcare surveys the growing interest in the human microbiome in in vitro diagnostics (IVD) and other healthcare applications, touching on areas such as metagenomics, metabolomic profiling, and microbiome diagnostics, among others.
While study of the microbiome has attracted enthusiastic media attention and venture capital, its findings are largely preliminary. Still, some IVD companies have already launched tests to measure changes in the microbiome to monitor disease progress.
Human Microbiome Applications in IVD and Other Healthcare
notes selected molecular microbiome-based tests, microbiome-based diagnostic biomarkers, and precision or personalized medicine approaches to the microbiome.
Human Microbiome Applications in IVD and Other Healthcare notes pharmaceutical company interest in the microbiome as well. Spurred on by the Human Microbiome Project, pharmaceutical companies have become more interested in microbiome research. Many players in the microbiome market are amassing knowledge and data about the microbiome in order to partner with pharmaceutical firms interested in developing new therapeutics.
Microbiome-based therapeutic approaches are discussed, including fecal microbiota transplants (FMT) and selected novel therapies. Select current microbiome-related drug candidates are noted in Human Microbiome Applications in IVD and Other Healthcare as well.
Microbiome companies and start-ups offer a wide array of products and services. They can be roughly grouped into therapeutics-based companies, research-based companies, and direct-to-consumer service providers. Despite the fact that efforts to develop microbiome-based diagnostics and therapies remain in their early stages, microbiome companies have attracted significant investment, which is discussed in the report.
Key Topics Covered:
1: Executive Summary
Introduction
Large-Scale Microbiome Projects
Scope Of The Report
Methodology
2: Human Microbiome In Ivd And Other Healthcare Applications
Microbiome - Bacteria In Disease Processes
Growing Interest In The Microbiome
Metagenomics
Metabolomic Profiling
Microbiome Diagnostics
Selected Molecular Microbiome-based Tests
Diagnostic Biomarkers
Precision or Personalized Medicine Approaches
PHARMA COMPANY INTEREST IN THE MICROBIOME
Agreements, Investments
Fecal Microbiota Transplantation (FMT)
Other Selected Microbiome-related Therapeutic Approaches
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030
The global market for Laboratory...
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...
During an awards ceremony to present the 2024 list of Best Workplacestm in Canada, Great Place to Work® announced the 50 Best Workplacestm in Canada with 100-999 employees....